Roberta M. Johnke - Publications

Physics East Carolina University, Greenville, NC, United States 
Oncology, Molecular Biology, Cell Biology

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Johnke RM, Sattler JA, Allison RR. Radioprotective agents for radiation therapy: future trends. Future Oncology (London, England). 10: 2345-57. PMID 25525844 DOI: 10.2217/Fon.14.175  0.6
2010 Lee TK, O'Brien KF, Wang W, Johnke RM, Sheng C, Benhabib SM, Wang T, Allison RR. Radioprotective effect of American ginseng on human lymphocytes at 90 minutes postirradiation: a study of 40 cases. Journal of Alternative and Complementary Medicine (New York, N.Y.). 16: 561-7. PMID 20491513 DOI: 10.1089/Acm.2009.0590  0.6
2009 Lee TK, O'Brien KF, Wang W, Sheng C, Wang T, Johnke RM, Allison RR. American Ginseng Modifies Cs-Induced DNA Damage and Oxidative Stress in Human Lymphocytes. The Open Nuclear Medicine Journal. 1: 1-8. PMID 19946576 DOI: 10.2174/1876388X00901010001  0.6
2009 Johnke RM, Edwards JM, Evans MJ, Nangami GN, Bakken NT, Kilburn JM, Lee TK, Allison RR, Karlsson UL, Arastu HH. Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression. In Vivo (Athens, Greece). 23: 827-33. PMID 19779119  0.6
2008 Johnke RM, Smith ES, Cariveau MJ, Evans MJ, Kilburn JM, Bakken NT, Nangami GN. Radioprotection of murine gastrointestinal epithelium by interleukin-1alpha involves down-regulation of the apoptotic response. Anticancer Research. 28: 3601-7. PMID 19189640  0.6
2008 Lee TK, Wang W, O'Brien KF, Johnke RM, Wang T, Allison RR, Diaz AL. Effect of North American ginseng on 137Cs-induced micronuclei in human lymphocytes: a comparison with WR-1065. Phytotherapy Research : Ptr. 22: 1614-22. PMID 18803249 DOI: 10.1002/Ptr.2533  0.6
2007 Menezes PFC, Bagnato VS, Johnke RM, Bonnerup C, Sibata CH, Allison RR, Perussi JR. Photodynamic therapy for Photogem® and Photofrin® using different light wavelengths in 375 human melanoma cells Laser Physics Letters. 4: 546-551. DOI: 10.1002/lapl.200710023  0.6
2006 Cariveaua MJ, Kalmus GW, Johnke RM, Allison RR, Evans M, Holbert D. Correlations between radiation-induced double strand breaks and cell cycle checkpoints in X-irradiated NIH/3T3 fibroblasts. Anticancer Research. 26: 3311-6. PMID 17094446  0.6
2005 Johnke RM, Edwards JM, Kovacs CJ, Evans MJ, Daly BM, Karlsson UL, Lee TK, Allison RR, Arastu HH, Cariveau MJ, O'Brien KF. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression. Anticancer Research. 25: 3159-66. PMID 16080580  0.6
2005 Lee TK, Johnke RM, Allison RR, O'Brien KF, Dobbs LJ. Radioprotective potential of ginseng. Mutagenesis. 20: 237-43. PMID 15956041 DOI: 10.1093/Mutage/Gei041  0.6
2005 Cariveau MJ, Kovacs CJ, Allison RR, Johnke RM, Kalmus GW, Evans M. The expression of p21/WAF-1 and cyclin B1 mediate mitotic delay in x-irradiated fibroblasts. Anticancer Research. 25: 1123-9. PMID 15868955  0.6
2004 Ahmed FE, James SI, Lysle DT, Dobbs LJ, Johnke RM, Flake G, Stockton P, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Allison RR. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis. Digestive Diseases and Sciences. 49: 1889-98. PMID 15628722 DOI: 10.1007/S10620-004-9589-9  0.6
2004 Ahmed FE, Dobbs LJ, Johnke RM, James S, Lysle DT, Sinar DR, Naziri W, Evans MJ, Kovacs CJ, Daly BM, Allison RR. Isolation of circulating colon carcinoma cells for reverse transcriptase polymerase chain reaction. Analytical Biochemistry. 332: 394-7. PMID 15325309 DOI: 10.1016/J.Ab.2004.05.018  0.6
2004 Lee TK, Allison RR, O'Brien KF, Khazanie PG, Johnke RM, Brown R, Bloch RM, Tate ML, Dobbs LJ, Kragel PJ. Ginseng reduces the micronuclei yield in lymphocytes after irradiation. Mutation Research. 557: 75-84. PMID 14706520 DOI: 10.1016/J.Mrgentox.2003.10.002  0.6
2003 Kovacs CJ, Daly BM, Evans MJ, Johnke RM, Lee TK, Karlsson UL, Allison R, Eaves GS, Biggs LM. Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate. Cytokine. 23: 151-63. PMID 12967640 DOI: 10.1016/S1043-4666(03)00185-6  0.6
2003 Lee TK, Allison RR, O'Brien KF, Johnke RM, Christie KI, Naves JL, Kovacs CJ, Arastu H, Karlsson UL. Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. International Journal of Radiation Oncology, Biology, Physics. 57: 222-9. PMID 12909237 DOI: 10.1016/S0360-3016(03)00411-5  0.6
1998 Kovacs CJ, Kerr JA, Daly BM, Evans MJ, Johnke RM. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression. Anticancer Research. 18: 1805-12. PMID 9673408  0.6
1997 Kovacs CJ, Evans MJ, Daly BM, Thomas-Patterson D, Johnke RM, Powell DS. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 17: 453-60. PMID 9282825  0.6
1997 Johnke RM, Abernathy RS, Kovacs CJ, Evans MJ, Biggs LE, Daly BM, Loven DP. Antioxidant enzyme activity in murine hematopoietic bone marrow following treatment with interleukin 1 alpha: influence of tumor. Anticancer Research. 17: 2169-74. PMID 9216682  0.6
1996 Kovacs CJ, Powell DS, Evans MJ, Thomas-Patterson D, Johnke RM. Enhanced platelet recovery in myelosuppressed mice treated with interleukin-1 and macrophage colony-stimulating factor: potential interactions with cytokines having megakaryocyte colony-stimulating activity. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 16: 187-94. PMID 8697140  0.6
1995 Kovacs CJ, Evans MJ, Roberts C, Harrell J, Abernathy R, Gooya J, Johnke RM. Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF. Experimental Hematology. 23: 1016-23. PMID 7635181  0.6
1994 Kovacs CJ, Harrell JP, Evans MJ, Abernathy RS, Roberts CJ, Johnke RM. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF). Stem Cells (Dayton, Ohio). 12: 103-13. PMID 8142915 DOI: 10.1002/Stem.5530120117  0.6
1992 Kovacs CJ, Harrell JP, Evans MJ, Johnke RM. Absence of interleukin 1 alpha radioprotection in tumor-bearing animals: elevated plasma levels of prostaglandin E versus a preexisting primed marrow. Journal of Leukocyte Biology. 51: 53-8. PMID 1740644 DOI: 10.1002/Jlb.51.1.53  0.6
1992 Kovacs CJ, Harrell JP, Gooya JM, Evans MJ, Johnke RM. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF. Experimental Hematology. 20: 582-9. PMID 1587305  0.6
1991 Johnke RM, Abernathy RS. Accelerated marrow recovery following total-body irradiation after treatment with vincristine, lithium or combined vincristine-lithium International Journal of Cell Cloning. 9: 78-88. PMID 2010658 DOI: 10.1002/Stem.5530090110  0.6
1991 Johnke RM, Loven DP, Abernathy RS, Bennett MJ, Murphy SA. Marrow antioxidant enzyme activity in tumor-bearing and non-tumor-bearing mice following vincristine treatment International Journal of Radiation Oncology, Biology, Physics. 20: 369-372. PMID 1991702 DOI: 10.1016/0360-3016(91)90122-K  0.6
1990 Johnke RM, Abernathy RS. Accelerated postirradiation recovery of hematopoietic marrow following priming with low doses of vincristine Radiation Research. 122: 234-240. PMID 2356276 DOI: 10.2307/3577751  0.6
1988 Kovacs CJ, Evans MJ, Hooker JL, Johnke RM. Long-term consequences of chemotherapeutic agents on hematopoiesis: Development of altered radiation tolerance Nci Monographs. 45-49. PMID 3352788  0.6
1988 Johnke RM, Kovacs CJ, Loven DP, Abernathy RS, Hooker JL. Altered radiosensitivity of hematopoietic stem cells by vincristine pretreatment: Superoxide dismutase activity as a possible mechanism Nci Monographs. 193-197. PMID 3352765  0.6
1986 Kovacs CJ, Johnke RM, Evans MJ, Emma DA, Hooker JL. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors Experimental Hematology. 14: 165-172. PMID 3948928  0.6
1985 Kovacs CJ, Johnke RM, Emma DA, Scarantino CW. Effect of prolonged expansion of marrow progenitor compartments following doxorubicin (ADR) on subsequent radiation tolerance Experimental Hematology. 13: 89-94. PMID 3987840  0.6
1985 Kovacs CJ, Emma DA, Evans MJ, Johnke RM, Scarantino CW. Haemopoietic modulation in tumour-bearing animals: Enhanced progenitor-cell production in femoral marrow Cell and Tissue Kinetics. 18: 235-246. PMID 3986868  0.6
1985 Kovacs CJ, Johnke RM, Emma DA, Scarantino CW, Brindle MT, Pogrow RM, Evans MJ. Residual adriamycin (AdR)-induced hematopoietic damage: a consideration for subsequent radiotherapy International Journal of Radiation Oncology, Biology, Physics. 11: 1955-1961. PMID 3902751 DOI: 10.1016/0360-3016(85)90277-9  0.6
1984 Kovacs CJ, Pogrow RM, Evans MJ, Johnke RM, Emma DA. Enhancement of colony-stimulating activity (CSA) on murine CFU-gm by te H-4-II-E2 (H4) tumor cell line of the rat International Journal of Cell Cloning. 2: 368-382. PMID 6335157 DOI: 10.1002/stem.5530020605  0.6
Show low-probability matches.